VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,151,768 | -59.8% | 2,897,734 | +5.3% | 0.01% | -57.1% |
Q2 2023 | $67,499,593 | +5.5% | 2,751,716 | +0.1% | 0.03% | +3.7% |
Q1 2023 | $63,965,623 | +7.4% | 2,748,845 | +16.8% | 0.03% | 0.0% |
Q4 2022 | $59,576,171 | +32.4% | 2,353,859 | +0.8% | 0.03% | +22.7% |
Q3 2022 | $45,006,000 | -36.9% | 2,334,318 | -16.6% | 0.02% | -33.3% |
Q2 2022 | $71,330,000 | -10.3% | 2,800,537 | -9.4% | 0.03% | +6.5% |
Q1 2022 | $79,503,000 | -27.5% | 3,091,105 | +17.9% | 0.03% | -20.5% |
Q4 2021 | $109,731,000 | +18.0% | 2,620,753 | +22.6% | 0.04% | +5.4% |
Q3 2021 | $93,024,000 | -7.2% | 2,137,492 | +0.8% | 0.04% | -7.5% |
Q2 2021 | $100,282,000 | +8.7% | 2,121,026 | +17.9% | 0.04% | 0.0% |
Q1 2021 | $92,223,000 | +16.1% | 1,798,779 | -39.4% | 0.04% | +8.1% |
Q4 2020 | $79,451,000 | +11.2% | 2,966,806 | +42.5% | 0.04% | -2.6% |
Q3 2020 | $71,455,000 | -10.0% | 2,081,425 | +7.4% | 0.04% | -19.1% |
Q2 2020 | $79,436,000 | +10534.0% | 1,938,872 | +8793.9% | 0.05% | +4600.0% |
Q1 2020 | $747,000 | – | 21,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |